Welcome to the PCPA Podcast series with a focus on Cancer Patient Management.
Episode 9: “Urothelial Carcinoma and Emerging ADCs”
In our latest podcast we discuss urothelial carcinoma and the latest advances in treating with antibody drug conjugates (ADCs), as a new therapeutic option. Dr Tony Michele, Medical Oncologist from Adelaide Oncology and Haematology, part of the Genesis Care Group, and PCPA Board member is joined by Dr Elizabeth Liow, Medical Oncologist at Monash in Melbourne and Dr Laurence Krieger, Medical Oncologist at Genesis Care North Shore Hub in Sydney. Our podcasters deep experience in managing these patients is invaluable in this transforming field of expertise.
Episode 8: “CAR T-cell Therapy in Australia: Paradigm Changing Technology”
In this PCPA podcast we unpack the transformative impact of CAR T-cell therapy.
PCPA Board Member, haematologist and Chief Medical Officer at ICON Group, Dr Ian Irving, leads the discussion on how this innovative cancer care technology is reshaping the landscape of haematologic malignancies.
CAR T-cell therapy leverages a patient’s own immune system to target and eradicate cancer cells with remarkable precision.
To understand how to integrate CAR T-cell therapy into cancer care practice, Dr Irving delves deep into this exciting new therapy with Associate Professor Mary Ann Anderson, haematologist from the Peter MacCallum Cancer Centre in Melbourne and Dr Allison Barraclough, haematologist from the Fiona Stanley Hospital in Perth.
Episode 7: “Leadership Stories: Women in Oncology Research”
In this PCPA podcast we focus on Leadership Stories: Women in Oncology Research, launched on International Women’s Day 2024. Professor Fran Boyle, Medical Oncologists and Supportive care Physician from the Mater Hospital in Sydney discusses the unique challenges and opportunities with Professor Victoria Atkinson from Greenslopes Private Hospital and the Princess Alexandra Hospital in Brisbane and also Dr Amy Davies, Medical Oncologist and Research Scientist from Victoria.
https://embracing-the-challenge-advancing-cancer-care.simplecast.com/episodes/leadership-stories-women-in-oncology-research
Episode 6. “The What, When, Why and How of IDH Mutations in Cancer?”
In this PCPA podcast we discuss The What, When, Why and How of IDH Mutations in Cancer? The discussion covers the understanding of IDH mutations in cancer, a completely new enzyme driving cancer in both solid tumours and in haematology. Experts are on hand to cover the nuances in molecular testing and review current and future therapies and trends in these patient populations.
Dr Shehara Mendis, Medical Oncologist from Cabrini Hospital in Melbourne chairs this discussion with Dr Michael Rodriguez, Consultant Neuropathologist, St Vincent’s Hospital and POW Hospital Sydney; Douglass Hanly Moir Pathology and Associate Professor Daniel Thomas, a Clinical Haematologist and Cancer Scientist from the University of Adelaide.
Episode 5. “Most Patients With Cancer are Older – How Does this Impact their Care?”
In this PCPA podcast we discuss “Most Patients With Cancer are Older – How Does this Impact their Care?” The conversation explores this specialised field which focuses on the care of older adults with cancer. Since more than 50% of patients will be over 65 years of age in the next few years and as an oncologist treating older patients with cancer, it’s crucial to understand the unique challenges and considerations involved in their care .
A/Professor Christopher Steer , medical oncologist from Albury/Wodonga and President of the Private Cancer Physicians of Australia is joined by Dr Etienne Brain, MD, PhD, senior medical oncologist at Institut Curie, in Saint-Cloud, France, who was honoured with the 2022 B.J. Kennedy Geriatric Oncology Award for his career-long contributions to advancing clinical research in breast cancer in older populations.
Episode 4. Voluntary Assisted Dying: What you need to know.
How do doctors navigate the moral and medical minefield of Voluntary Assisted Dying (VAD)? How do doctors balance the views and hopes of their patients with their own beliefs and values?
PCPA Board member, Victorian Director and medical oncologist, Dr Cameron McLaren, delves into the rapidly evolving landscape of controversial and legalised Voluntary Assisted Dying (VAD).
Dr McLaren is joined by fellow VAD pioneers, PCPA member and Medical Oncologist specialising in Cancer Genetics, Dr Hilda High and Ms Laurie Draper from the Victorian Voluntary Assisted Dying Care Navigator Service.
In this special Cancer Patient Management podcast series, our PCPA experts tackle the vexed issues facing doctors, navigators and their patients who are contemplating VAD as an end-of-life choice.
With all states now embracing VAD laws and more and more Australians with cancer wanting this option, our podcasters urge all doctors to undergo Voluntary Assisted Dying training, even if they do not to want to be involved in the VAD journey themselves.
Episode 3: Precision Medicine for Australian Patients with Cancer
Molecular profiling plays a crucial role in optimizing cancer care by enabling personalized treatment decisions, improving treatment outcomes, and offering potential avenues for targeted therapies and clinical trial participation. In this PCPA Podcast, Professor Desmond Yip, PCPA Secretary and Treasurer and Senior Staff Specialist in Medical Oncology at the Canberra Hospital is joined by Professor Lorraine Chantrill, Senior Staff Specialist Medical Oncologist and Head of Service for Medical Oncology across the Illawarra Shoalhaven Local Health District (ISLHD), and Area Clinical Director of Clinical Trials and also Dr Vivek Rathi, Director of Operations, Group Medical Director, Group Molecular Pathologist at LifeStrands Genomics. In this podcast, they discuss precision medicine for Australian patients with cancer, current genetic pathology and actionable targets. We look to the future of comprehensive genomic profiling (CGP) and how to make this a clinical solution for all.
Episode 2: Antibody-Drug Conjugates: Transforming Breast Cancer Treatment
The Private Cancer Physician’s Podcast series on Managing Patients with Cancer is pleased to release its new podcast: Antibody-Drug Conjugates: Transforming Breast Cancer Treatment. In this podcast, we discuss antibody-drug conjugates (ADCs) and the transformative role they are playing in the fight against metastatic breast cancer. ADCs are “smart bombs” that provide a new construct to treat metastatic breast cancer, with higher efficacy and less off target toxicities. Dr Richard de Boer, Medical Oncologist from the Peter MacCallum Cancer Centre is joined by Professor Hope Rugo, Director, Breast Oncology and Clinical Trials Education and Medical Director of Cancer Infusion Services, UCSF as well as Dr Belinda Yeo, Medical Oncologist from the Austin Hospital in Melbourne, Australia, and Clinician Scientist from the Olivia Newton-John Cancer Research Institute. Produced by ScienceToLife.
This episode is made possible with the support from
Episode 1:
The Patient Doctor
What happens when a Doctor can experience the health system through patient eyes? Dr Ben Bravery, author of the Patient Doctor and a Registrar in Sydney, Australia, tells his story of being diagnosed with Stage III colorectal cancer and enabling change from within the health system. In discussion are our PCPA leads, Dr Cameron McLaren, Medical Oncologist at Monash Health and St John of God Melbourne Australia and A/Prof Katrin Sjoquist, Medical Oncologist at St George Private Hospital and Clinical Lead at the NHMRC Clinical Trials Centre, we explore how a patient becomes the centrepoint for the core of healthcare decisions.
This episode is made possible with the support from 